메뉴 건너뛰기
Vnitrni Lekarstvi
Volumn 55, Issue 4, 2009, Pages 368-370
Drugs influencing bone metabolism in diabetic patients;Léky ovlivňující kostní metabolizmus diabetiků
Author keywords

Diabetes mellitus; Osteoporosis; PPAR; Therapy
Indexed keywords

GLITAZONE DERIVATIVE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; ROSIGLITAZONE; SOMATOMEDIN;
EID: 66349088278     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper
Times cited : (5)
References (9)
  • 1
    • 47049100977 scopus 로고    scopus 로고
    • Bone and fat conection in aging bone
    • Duque G. Bone and fat conection in aging bone. Curr Opin Rheumatol 2008; 20: 429-434.
    • (2008) Curr Opin Rheumatol , vol.20 , pp. 429-434
    • Duque, G.1
  • 2
    • 67049166407 scopus 로고    scopus 로고
    • Osteoporosis: Other Secondary Causes
    • 7th ed. Washington DC: American Society for Bone and Mineral Research
    • Hamdy NAT. Osteoporosis: Other Secondary Causes. In: Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 7th ed. Washington DC: American Society for Bone and Mineral Research 2009: 276-279.
    • (2009) Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism , pp. 276-279
    • Hamdy, N.A.T.1
  • 3
    • 34250847265 scopus 로고    scopus 로고
    • Rosiglitazone induces decreases in bone mass and strenght that are reminiscent of aged bone
    • Lazarenko OP, Rzonca SO, Hogue WR et al. Rosiglitazone induces decreases in bone mass and strenght that are reminiscent of aged bone. Endocrinology 2007; 148: 2669-2680.
    • (2007) Endocrinology , vol.148 , pp. 2669-2680
    • Lazarenko, O.P.1    Rzonca, S.O.2    Hogue, W.R.3
  • 4
    • 29344470714 scopus 로고    scopus 로고
    • Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat
    • Lazarenko OP, Rzonca SO, Suva LJ et al. Netoglitazone is a PPAR-gamma ligand with selective effects on bone and fat. Bone 2006; 38: 74-84.
    • (2006) Bone , vol.38 , pp. 74-84
    • Lazarenko, O.P.1    Rzonca, S.O.2    Suva, L.J.3
  • 5
    • 42949088130 scopus 로고    scopus 로고
    • Use of thiazolidinediones and fracture risk
    • Meier C, Kraenzlin ME, Bodmer M et al. Use of thiazolidinediones and fracture risk. Arch Intern Med 2008; 168: 820-825.
    • (2008) Arch Intern Med , vol.168 , pp. 820-825
    • Meier, C.1    Kraenzlin, M.E.2    Bodmer, M.3
  • 6
    • 67049170034 scopus 로고    scopus 로고
    • A New PPAR-γ Function in Bone
    • 6
    • 6.Takada I, KatoS. A New PPAR-γ Function in Bone. IBMS BoneKEy 2008; 5: 258-261.
    • (2008) IBMS BoneKEy , vol.5 , pp. 258-261
    • Takada, I.1    KatoS, A.2
  • 7
    • 34247094322 scopus 로고    scopus 로고
    • Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation
    • Valcourt U, Merle B, Cineyts E et al. Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation.J Biol Chem 2007; 282: 5691-5703.
    • (2007) J Biol Chem , vol.282 , pp. 5691-5703
    • Valcourt, U.1    Merle, B.2    Cineyts, E.3
  • 8
    • 33746669941 scopus 로고    scopus 로고
    • Vitamin D receptor polymorphisms and diseases
    • Valdivielso JM, Fernandez E. Vitamin D receptor polymorphisms and diseases. Clin Chim Acta 2006; 371: 1-12.
    • (2006) Clin Chim Acta , vol.371 , pp. 1-12
    • Valdivielso, J.M.1    Fernandez, E.2
  • 9
    • 36849034568 scopus 로고    scopus 로고
    • PPAR-y regulates osteoclastogenesis in mice
    • Wan Y, Chong LW, Evans RM. PPAR-y regulates osteoclastogenesis in mice. Nat Med 2007; 13: 1496-1503.
    • (2007) Nat Med , vol.13 , pp. 1496-1503
    • Wan, Y.1    Chong, L.W.2    Evans, R.M.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.